H1N1v
Showing 1 - 25 of >10,000
H1N1v Influenza Trial in Gentofte/Copenhagen, Næstved (Focetria)
Completed
- H1N1v Influenza
- Focetria
-
Gentofte, Denmark
- +1 more
Nov 14, 2022
Children After Hospitalization in Intensive Care Unit
Not yet recruiting
- Renal Disease
- +7 more
- neurocognitive tests
-
Calgary, Alberta, Canada
- +7 more
Nov 3, 2023
Cystic Fibrosis Pulmonary Exacerbation Trial in Canada (Prednisone, Placebos)
Recruiting
- Cystic Fibrosis Pulmonary Exacerbation
- Prednisone
- Placebos
-
Calgary, Alberta, Canada
- +11 more
Nov 23, 2022
Asthma Trial in Canada (Vitamin D, Placebo)
Recruiting
- Asthma
- Vitamin D
- Placebo
-
Vancouver, British Columbia, Canada
- +8 more
Jan 30, 2023
Oral Upadacitinib Tablets to Assess Change in Disease Symptoms
Recruiting
- Rheumatoid Arthritis (RA)
-
Edmonton, Alberta, Canada
- +38 more
Jan 17, 2023
Bipolar Disorder Trial in Canada (Cannabidiol, Placebo)
Not yet recruiting
- Bipolar Disorder
- Cannabidiol
- Placebo
-
Calgary, Alberta, Canada
- +7 more
May 18, 2023
Recurrent Pregnancy Loss Trial in Vancouver (Data Registry)
Recruiting
- Recurrent Pregnancy Loss
- Data Registry
-
Vancouver, British Columbia, CanadaBC Women's Hospital & Health Centre
Aug 15, 2023
Anterior vs Posterior Surgery for Lumbar Isthmic
Recruiting
- Isthmic Spondylolisthesis
- Interbody fusion surgery
-
Vancouver, British Columbia, CanadaVancouver General Hospital
Jan 30, 2023
Local Recurrence Following Breast Conserving Surgery and
Active, not recruiting
- Breast Cancer
-
Calgary, Alberta, Canada
- +26 more
Sep 19, 2022
Adults With Severe Eosinophilic Asthma on Benralizumab.
Active, not recruiting
- Severe Eosinophilic Asthma
- Survey Administration
-
Calgary, Alberta, Canada
- +19 more
Dec 1, 2022
Critical Illness Trial in Canada (Albumin Fluid Resuscitation Optimization Intervention, Usual Practice)
Completed
- Critical Illness
- Albumin Fluid Resuscitation Optimization Intervention
- Usual Practice
-
Calgary, Alberta, Canada
- +14 more
Oct 31, 2022
Oropharyngeal Cancer Trial in Canada (Radiation, Cisplatin)
Active, not recruiting
- Oropharyngeal Cancer
- Radiation
- Cisplatin
-
Prince George, British Columbia, Canada
- +13 more
Dec 12, 2022
CVD Risk Profile in Children With HCM
Recruiting
- Hypertrophic Cardiomyopathy
-
Edmonton, Alberta, Canada
- +9 more
Aug 18, 2022
Elbow Fracture, Elbow Injury, Elbow Dislocation Trial in Canada, United States (Lactose Placebo, Ketotifen Fumarate 2mg,
Recruiting
- Elbow Fracture
- +2 more
- Lactose Placebo
- +2 more
-
Baltimore, Maryland
- +16 more
Dec 8, 2022
HR+ HER2- Men, Pre/Postmenopausal Advanced Breast Cancer Trial in Canada (Endocrine therapy may include one of the following
Active, not recruiting
- HR+ HER2- Men, Pre/Postmenopausal Advanced Breast Cancer
- Endocrine therapy may include one of the following therapies: letrozole, anastrozole, exemestane, tamoxifen or fulvestrant
- Endocrine therapy in combination with targeted therapy may include: everolimus plus exemestane or CDK4/6 inhibitor plus endocrine therapy
-
Calgary, Alberta, Canada
- +24 more
Sep 12, 2022
Pain Perception Trial in Montréal (Endocare)
Completed
- Pain Perception
- Endocare
-
Montréal, Quebec, CanadaCentre de recherche de l'institut universitaire de santé mentale
Nov 11, 2023
Medical Education, Simulation Trial in Vancouver (Simulation on Pediatric Status Epilepticus, Didactic Lecture on Pediatric
Recruiting
- Medical Education
- Simulation
- Simulation on Pediatric Status Epilepticus
- Didactic Lecture on Pediatric Status Epilepticus
-
Vancouver, British Columbia, CanadaBC Children's Hospital
Oct 17, 2023
Lymphoma, Non-Hodgkin, Multiple Myeloma, Advanced Solid Tumors Trial in Canada (Olaparib, Dasatinib, Nivolumab plus Ipilimumab)
Recruiting
- Lymphoma, Non-Hodgkin
- +2 more
- Olaparib
- +13 more
-
Edmonton, Alberta, Canada
- +9 more
Jan 9, 2023
Renal Cell Carcinoma Trial in Canada, United States (Nivolumab, Ipilimumab)
Terminated
- Renal Cell Carcinoma
- Nivolumab
- Ipilimumab
-
Saint Louis, Missouri
- +11 more
Dec 15, 2022
Endogenous Cushing Syndrome Trial in Edmonton, Halifax, Sherbrooke (Intervention/Treatment)
Active, not recruiting
- Endogenous Cushing Syndrome
-
Edmonton, Alberta, Canada
- +2 more
Nov 9, 2023
Pancreatic Adenocarcinoma Trial in Canada (Gemcitabine, Nab-paclitaxel, Durvalumab)
Active, not recruiting
- Pancreatic Adenocarcinoma
- Gemcitabine
- +3 more
-
Calgary, Alberta, Canada
- +26 more
May 9, 2022
Opioid Use, Affective Symptoms Trial in Oslo (Placebo, Morphine 2.5 mg i.v., Morphine 5 mg i.v.)
Recruiting
- Opioid Use
- Affective Symptoms
- Placebo
- +9 more
-
Oslo, NorwayHarald Lenz
Dec 13, 2022